Sort by 'shares'
New Developments in Breast Cancer Screening and Treatment
Breast cancer is the second most common cancer in women (although men can get it too). Some breast cancers are driven by inherited mutations while most are sporadic, driven by unknown causes or by environmental or behavioral factors like obesity,…
Allogenic Transplants with Myeloma Expert Dr. Vij & MMRF
Dr. Ravi Vij of Washington University School of Medicine discusses the pros and cons of Allogenic Transplants and Anne Quinn Young of MMRF provides updates on activities of MMRF.
Myeloma with The MMRF
Towards the end of last year in 2013, MMRF rolled out three important cancer research initiatives - big data and genomic sequencing, open access by sharing research data, and empowering patients to find clinical trials that are best for them…
Post-Transplant Outcomes in High Risk Multiple Myeloma
Treatment of patients with myeloma has changed dramatically in the past years due to development of new agents and myeloma specific targets. Despite these advancements, long term benefits remains less clear in high-risk multiple myeloma patients. Myeloma is classified as…
Alzheimer’s or Dementia. What’s the Difference?
Over 10 million people in the US have a neurodegenerative condition. Half of these people have Alzheimer's Disease making it the most common neurodegenerative condition in the US. Among the remaining, a large population suffer from frontotemporal dementia (FTD). However,…